Biological drugs help in the prevention and treatment of numerous chronic diseases such as diabetes, cancer, auto-immune diseases, and blood-related disorders. With the rise in global geriatric population and a subsequent rise in the patient pool, the demand for biological drugs has grown remarkably.

The report segments the biological drugs market on the basis of vaccine, monoclonal antibody, therapeutic protein, and geography. By therapeutic protein, biological drugs are divided into Levemir, Neulasta, Eylea, Rebif, NovoLog, Enbrel, Avonex, Neupogen, Humalog, Victoza, Lantus, Epogen, Aranesp, and Betaseron. By monoclonal antibody, biological drugs are segmented into Avastin, Rituxan, Lucentis, Humira, Herceptin, and Remicade. By vaccine, the biological drugs market is fragmented into Gardasil, Prenvar 13, Fluzone, Cervarix, and Varivax.

Browse the full Biological Drugs Market Report at :
http://www.transparencymarketresearch.com/biological-drugs-market.html

The biological drugs market research report is a comprehensive database of accurate and updated analytical information, with qualitative as well as quantitative inputs from various sources. With the help of tools such as Porter’s Five Forces Analysis, value chain analysis, market attractiveness analysis, and SWOT analysis, the report gives a well-rounded view of the market. Opinions and strategic recommendations by industry experts are offered to provide a better understanding of the biological drugs market.

Overview of the global biological drugs market

According to the report, the global biological drugs market is anticipated to grow from US$161,056.5 million in 2014 to US$287,139.7 million by 2020, at a 10.1% CAGR from 2014 to 2020.

The growing prevalence of chronic diseases around the world is the primary factor driving the biological drugs market. In addition, rise in the global geriatric population and support from numerous government organizations has also fueled the growth of the biological drugs market. The field of biomedical science has received a tremendous boost in recent times, thanks to funding and encouragement from private and public agencies. The development of new and improved biological drugs is further estimated to drive the market by 2020. In contrast, patent expiration of blockbuster drugs, high cost of biological drugs, and the possible adverse effects of biological injectable medicines are projected to restrain the growth of the biological drugs market.

Browse the full Biological Drugs Market press release at :
http://www.transparencymarketresearch.com/pressrelease/biological-drugs-market.htm

North America dominates the global biological drugs market, followed by Europe, owing to increased adoption and use of biological drugs for the treatment of diabetes, cancer, and other fatal diseases. The biological drugs market in Asia has, in recent years, attracted many manufacturers owing to low production cost, rise in government aid, increasing investment in biotechnology, and growth of medical R&D infrastructure.

Companies mentioned in the research report

Being immensely competitive, the biological drugs market is marked by the presence of a large number of established and new players operating at a local and global level. These include Baxter International Inc., Pfizer Inc., Abbott Laboratories, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc., Biogen Idec, Novartis AG, Eli Lilly and Company, and Amgen Inc.

Get Free Sample Report Biological Drugs Market :
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1694

Segmentation based on therapeutic protein

Levemir

Neulasta

Eylea

Rebif

NovoLog

Enbrel

Avonex

Neupogen

Humalog

Victoza

Lantus

Epogen

Aranesp

Betaseron

Segmentation based on monoclonal antibody (mAb)

Avastin

Rituxan

Lucentis

Humira

Herceptin

Remicade

Segmentation based on vaccine

Gardasil

Prenvar 13

Fluzone

Cervarix

Varivax

Major geographies analyzed under this research report are:

Europe

North America

Asia

Rest of the World

This report gives you access to decisive data such as:

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for the coming years

Key highlights of this report

Overview of key market forces propelling and restraining market growth

Up-to-date analyses of market trends and technological improvements

Pin-point analyses of market competition dynamics to offer you a competitive edge

An analysis of strategies of major competitors

An array of graphics and SWOT analysis of major industry segments

Detailed analyses of industry trends

A well-defined technological growth map with an impact-analysis

Offers a clear understanding of the competitive landscape and key product segments

About Us :

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.